Novo Integrated Sciences, Inc.
General ticker "NVOS" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $411.3K (TTM average)
Novo Integrated Sciences, Inc. does not follow the US Stock Market performance with the rate: -15.7%.
Estimated limits based on current volatility of 69.4%: low 0.00$, high 0.00$
Factors to consider:
- Total employees count: 115 (-9.4%) as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Integration of acquired clinics, Expansion into new markets, Cybersecurity threats, Economic downturns and volatility, Regulatory and compliance
Short-term NVOS quotes
Long-term NVOS plot
Financial data
| YTD | 2022-08-31 | 2023-08-31 | 2024-08-31 |
|---|---|---|---|
| Operating Revenue | $11.74MM | $12.57MM | $13.29MM |
| Operating Expenses | $36.76MM | $21.13MM | $23.37MM |
| Operating Income | $-25.03MM | $-8.55MM | $-10.08MM |
| Non-Operating Income | $-8.04MM | $-4.72MM | $-6.05MM |
| Interest Expense | $1.59MM | $0.36MM | $0.65MM |
| Income(Loss) | $-33.07MM | $-13.27MM | $-16.13MM |
| Taxes | $-0.02MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-32.85MM | $-13.21MM | $-16.17MM |
| Stockholders Equity | $22.31MM | $24.82MM | $14.89MM |
| Assets | $40.87MM | $35.56MM | $32.14MM |
| Operating Cash Flow | $-5.88MM | $-2.24MM | $-2.24MM |
| Capital expenditure | $0.19MM | $0.05MM | $0.05MM |
| Investing Cash Flow | $0.16MM | $-0.05MM | $-0.05MM |
| Financing Cash Flow | $-0.43MM | $0.76MM | $0.76MM |
| Earnings Per Share** | $-11.28 | $-1.30 | $-0.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.